Is Niagen Bioscience Inc (NASDAQ: NAGE) A Good Stock To Invest In Right Now?

Niagen Bioscience Inc (NASDAQ:NAGE) price on Friday, July 25, rose 0.54% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $9.32.

A look at the stock’s price movement, the close in the last trading session was $9.27, moving within a range at $9.23 and $9.4956. The beta value (5-Year monthly) was 2.142 while the PE ratio in trailing twelve months stood at 53.97. Turning to its 52-week performance, $14.69 and $2.53 were the 52-week high and 52-week low respectively. Overall, NAGE moved -30.50% over the past month.

Niagen Bioscience Inc’s market cap currently stands at around $734.13 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-07.

Turning to the stock’s technical picture we see that short term indicators suggest on average that NAGE is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.

The technical evaluation for the stock shows the PEG ratio is 1.10, with NAGE’s current price about -18.35% and -21.50% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 31.28, while 7-day volatility ratio is 5.36% and 5.73% in the 30-day chart. Further, Niagen Bioscience Inc (NAGE) has a beta value of 2.11.

If we refocus on Niagen Bioscience Inc (NASDAQ:NAGE), historical trading data shows that trading volumes averaged 1.17 over the past 10 days and 1.06 million over the past 3 months. The company’s latest data on shares outstanding shows there are 78.43 million shares.

The 36.77% of Niagen Bioscience Inc’s shares are in the hands of company insiders while institutional holders own 31.84% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.49 million on 2025-07-15, giving us a short ratio of 3.31. The data shows that as of 2025-07-15 short interest in Niagen Bioscience Inc (NAGE) stood at 675.0 of shares outstanding, with shares short rising to 3.27 million registered in 2025-06-13. Current price change has pushed the stock 203.58% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NAGE stock continues to rise going into the next quarter.

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.